The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sleep-Wake Disorder Market Research Report 2025
Synopsis
The sleep-wake disorder is a sign of an impending condition such as bipolar disorder. Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorder to restless leg syndrome.
The global Sleep-Wake Disorder market was valued at US$ 17200 million in 2023 and is anticipated to reach US$ 28080 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The major factors driving the market include the increasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries. Aging is a major factor driving the market growth for sleep apnea devices as the elderly are the most at risk for developing this disorder.
This report aims to provide a comprehensive presentation of the global market for Sleep-Wake Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep-Wake Disorder.
Report Scope
The Sleep-Wake Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleep-Wake Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep-Wake Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jazz Pharmaceuticals
Koninklijke Philips N.V.
Merck KGaA
Neurocrine Biosciences
RespireRx Pharmaceuticals Inc.
Medtronic PLC
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.
Segment by Type
Insomnia
Hypersomnia
Sleep Apnea
Circadian Rhythm Disorders
Others
Segment by Application
Therapies
Medications
Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep-Wake Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The sleep-wake disorder is a sign of an impending condition such as bipolar disorder. Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorder to restless leg syndrome.
The global Sleep-Wake Disorder market was valued at US$ 17200 million in 2023 and is anticipated to reach US$ 28080 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The major factors driving the market include the increasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries. Aging is a major factor driving the market growth for sleep apnea devices as the elderly are the most at risk for developing this disorder.
This report aims to provide a comprehensive presentation of the global market for Sleep-Wake Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep-Wake Disorder.
Report Scope
The Sleep-Wake Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleep-Wake Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleep-Wake Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jazz Pharmaceuticals
Koninklijke Philips N.V.
Merck KGaA
Neurocrine Biosciences
RespireRx Pharmaceuticals Inc.
Medtronic PLC
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.
Segment by Type
Insomnia
Hypersomnia
Sleep Apnea
Circadian Rhythm Disorders
Others
Segment by Application
Therapies
Medications
Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep-Wake Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep-Wake Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Insomnia
1.2.3 Hypersomnia
1.2.4 Sleep Apnea
1.2.5 Circadian Rhythm Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Sleep-Wake Disorder Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Therapies
1.3.3 Medications
1.3.4 Devices
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sleep-Wake Disorder Market Perspective (2019-2030)
2.2 Sleep-Wake Disorder Growth Trends by Region
2.2.1 Global Sleep-Wake Disorder Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sleep-Wake Disorder Historic Market Size by Region (2019-2024)
2.2.3 Sleep-Wake Disorder Forecasted Market Size by Region (2025-2030)
2.3 Sleep-Wake Disorder Market Dynamics
2.3.1 Sleep-Wake Disorder Industry Trends
2.3.2 Sleep-Wake Disorder Market Drivers
2.3.3 Sleep-Wake Disorder Market Challenges
2.3.4 Sleep-Wake Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleep-Wake Disorder Players by Revenue
3.1.1 Global Top Sleep-Wake Disorder Players by Revenue (2019-2024)
3.1.2 Global Sleep-Wake Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Sleep-Wake Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleep-Wake Disorder Revenue
3.4 Global Sleep-Wake Disorder Market Concentration Ratio
3.4.1 Global Sleep-Wake Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep-Wake Disorder Revenue in 2023
3.5 Sleep-Wake Disorder Key Players Head office and Area Served
3.6 Key Players Sleep-Wake Disorder Product Solution and Service
3.7 Date of Enter into Sleep-Wake Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleep-Wake Disorder Breakdown Data by Type
4.1 Global Sleep-Wake Disorder Historic Market Size by Type (2019-2024)
4.2 Global Sleep-Wake Disorder Forecasted Market Size by Type (2025-2030)
5 Sleep-Wake Disorder Breakdown Data by Application
5.1 Global Sleep-Wake Disorder Historic Market Size by Application (2019-2024)
5.2 Global Sleep-Wake Disorder Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sleep-Wake Disorder Market Size (2019-2030)
6.2 North America Sleep-Wake Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sleep-Wake Disorder Market Size by Country (2019-2024)
6.4 North America Sleep-Wake Disorder Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sleep-Wake Disorder Market Size (2019-2030)
7.2 Europe Sleep-Wake Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sleep-Wake Disorder Market Size by Country (2019-2024)
7.4 Europe Sleep-Wake Disorder Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleep-Wake Disorder Market Size (2019-2030)
8.2 Asia-Pacific Sleep-Wake Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sleep-Wake Disorder Market Size by Region (2019-2024)
8.4 Asia-Pacific Sleep-Wake Disorder Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sleep-Wake Disorder Market Size (2019-2030)
9.2 Latin America Sleep-Wake Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sleep-Wake Disorder Market Size by Country (2019-2024)
9.4 Latin America Sleep-Wake Disorder Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleep-Wake Disorder Market Size (2019-2030)
10.2 Middle East & Africa Sleep-Wake Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2019-2024)
10.4 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Detail
11.1.2 Jazz Pharmaceuticals Business Overview
11.1.3 Jazz Pharmaceuticals Sleep-Wake Disorder Introduction
11.1.4 Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2019-2024)
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Koninklijke Philips N.V.
11.2.1 Koninklijke Philips N.V. Company Detail
11.2.2 Koninklijke Philips N.V. Business Overview
11.2.3 Koninklijke Philips N.V. Sleep-Wake Disorder Introduction
11.2.4 Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2019-2024)
11.2.5 Koninklijke Philips N.V. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Sleep-Wake Disorder Introduction
11.3.4 Merck KGaA Revenue in Sleep-Wake Disorder Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Neurocrine Biosciences
11.4.1 Neurocrine Biosciences Company Detail
11.4.2 Neurocrine Biosciences Business Overview
11.4.3 Neurocrine Biosciences Sleep-Wake Disorder Introduction
11.4.4 Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2019-2024)
11.4.5 Neurocrine Biosciences Recent Development
11.5 RespireRx Pharmaceuticals Inc.
11.5.1 RespireRx Pharmaceuticals Inc. Company Detail
11.5.2 RespireRx Pharmaceuticals Inc. Business Overview
11.5.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Introduction
11.5.4 RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2019-2024)
11.5.5 RespireRx Pharmaceuticals Inc. Recent Development
11.6 Medtronic PLC
11.6.1 Medtronic PLC Company Detail
11.6.2 Medtronic PLC Business Overview
11.6.3 Medtronic PLC Sleep-Wake Disorder Introduction
11.6.4 Medtronic PLC Revenue in Sleep-Wake Disorder Business (2019-2024)
11.6.5 Medtronic PLC Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Vanda Pharmaceuticals Inc.
11.8.1 Vanda Pharmaceuticals Inc. Company Detail
11.8.2 Vanda Pharmaceuticals Inc. Business Overview
11.8.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Introduction
11.8.4 Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2019-2024)
11.8.5 Vanda Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sleep-Wake Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Insomnia
Table 3. Key Players of Hypersomnia
Table 4. Key Players of Sleep Apnea
Table 5. Key Players of Circadian Rhythm Disorders
Table 6. Key Players of Others
Table 7. Global Sleep-Wake Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Sleep-Wake Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Sleep-Wake Disorder Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Sleep-Wake Disorder Market Share by Region (2019-2024)
Table 11. Global Sleep-Wake Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Sleep-Wake Disorder Market Share by Region (2025-2030)
Table 13. Sleep-Wake Disorder Market Trends
Table 14. Sleep-Wake Disorder Market Drivers
Table 15. Sleep-Wake Disorder Market Challenges
Table 16. Sleep-Wake Disorder Market Restraints
Table 17. Global Sleep-Wake Disorder Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Sleep-Wake Disorder Market Share by Players (2019-2024)
Table 19. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2023)
Table 20. Ranking of Global Top Sleep-Wake Disorder Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Sleep-Wake Disorder Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sleep-Wake Disorder Product Solution and Service
Table 24. Date of Enter into Sleep-Wake Disorder Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sleep-Wake Disorder Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Sleep-Wake Disorder Revenue Market Share by Type (2019-2024)
Table 28. Global Sleep-Wake Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Sleep-Wake Disorder Revenue Market Share by Type (2025-2030)
Table 30. Global Sleep-Wake Disorder Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Sleep-Wake Disorder Revenue Market Share by Application (2019-2024)
Table 32. Global Sleep-Wake Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Sleep-Wake Disorder Revenue Market Share by Application (2025-2030)
Table 34. North America Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Sleep-Wake Disorder Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Sleep-Wake Disorder Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Sleep-Wake Disorder Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Sleep-Wake Disorder Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Sleep-Wake Disorder Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Sleep-Wake Disorder Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Sleep-Wake Disorder Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2025-2030) & (US$ Million)
Table 49. Jazz Pharmaceuticals Company Detail
Table 50. Jazz Pharmaceuticals Business Overview
Table 51. Jazz Pharmaceuticals Sleep-Wake Disorder Product
Table 52. Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 53. Jazz Pharmaceuticals Recent Development
Table 54. Koninklijke Philips N.V. Company Detail
Table 55. Koninklijke Philips N.V. Business Overview
Table 56. Koninklijke Philips N.V. Sleep-Wake Disorder Product
Table 57. Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 58. Koninklijke Philips N.V. Recent Development
Table 59. Merck KGaA Company Detail
Table 60. Merck KGaA Business Overview
Table 61. Merck KGaA Sleep-Wake Disorder Product
Table 62. Merck KGaA Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 63. Merck KGaA Recent Development
Table 64. Neurocrine Biosciences Company Detail
Table 65. Neurocrine Biosciences Business Overview
Table 66. Neurocrine Biosciences Sleep-Wake Disorder Product
Table 67. Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 68. Neurocrine Biosciences Recent Development
Table 69. RespireRx Pharmaceuticals Inc. Company Detail
Table 70. RespireRx Pharmaceuticals Inc. Business Overview
Table 71. RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Product
Table 72. RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 73. RespireRx Pharmaceuticals Inc. Recent Development
Table 74. Medtronic PLC Company Detail
Table 75. Medtronic PLC Business Overview
Table 76. Medtronic PLC Sleep-Wake Disorder Product
Table 77. Medtronic PLC Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 78. Medtronic PLC Recent Development
Table 79. Teva Pharmaceutical Industries Ltd. Company Detail
Table 80. Teva Pharmaceutical Industries Ltd. Business Overview
Table 81. Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Product
Table 82. Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd. Recent Development
Table 84. Vanda Pharmaceuticals Inc. Company Detail
Table 85. Vanda Pharmaceuticals Inc. Business Overview
Table 86. Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Product
Table 87. Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2019-2024) & (US$ Million)
Table 88. Vanda Pharmaceuticals Inc. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleep-Wake Disorder Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sleep-Wake Disorder Market Share by Type: 2023 VS 2030
Figure 3. Insomnia Features
Figure 4. Hypersomnia Features
Figure 5. Sleep Apnea Features
Figure 6. Circadian Rhythm Disorders Features
Figure 7. Others Features
Figure 8. Global Sleep-Wake Disorder Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Sleep-Wake Disorder Market Share by Application: 2023 VS 2030
Figure 10. Therapies Case Studies
Figure 11. Medications Case Studies
Figure 12. Devices Case Studies
Figure 13. Sleep-Wake Disorder Report Years Considered
Figure 14. Global Sleep-Wake Disorder Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Sleep-Wake Disorder Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Sleep-Wake Disorder Market Share by Region: 2023 VS 2030
Figure 17. Global Sleep-Wake Disorder Market Share by Players in 2023
Figure 18. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Sleep-Wake Disorder Revenue in 2023
Figure 20. North America Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Sleep-Wake Disorder Market Share by Country (2019-2030)
Figure 22. United States Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Sleep-Wake Disorder Market Share by Country (2019-2030)
Figure 26. Germany Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Sleep-Wake Disorder Market Share by Region (2019-2030)
Figure 34. China Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Sleep-Wake Disorder Market Share by Country (2019-2030)
Figure 42. Mexico Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Sleep-Wake Disorder Market Share by Country (2019-2030)
Figure 46. Turkey Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Sleep-Wake Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Jazz Pharmaceuticals Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 49. Koninklijke Philips N.V. Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 50. Merck KGaA Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 51. Neurocrine Biosciences Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 52. RespireRx Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 53. Medtronic PLC Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 55. Vanda Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
